Ledger.Open graph →
SEC Form D · filed June 18, 2024

Summit Therapeutics Inc

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Miami, FL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Mostafa Ronaghi · Miami, FLDirectorManmeet Soni · Miami, FLExec · DirectorYu Xia · Miami, FLDirectorRobert Booth · Miami, FLDirectorKenneth Clark · Miami, FLDirectorMahkam Zanganeh · Miami, FLExec · DirectorAlessandra Cesano · Miami, FLDirectorAlessandra Cesano · Miami, FLDirectorKenneth Clark · Miami, FLDirectorYu Xia · Miami, FLDirectorRobert Booth · Miami, FLDirectorMahkam Zanganeh · Miami, FLExec · DirectorManmeet Soni · Miami, FLExec · DirectorMostafa Ronaghi · Miami, FLDirectorUjwala Mahatme · Cambridge, MADirectorRobert Duggan · Palo Alto, CAExec · DirectorPhillipe Bucher · Zurich, V8DirectorZachary Wolfe · Los Angeles, CAExec · DirectorAlex P. Pease · New York, NYDirectorSpencer Brown · Westport, CTExec · DirectorKyle York · Manchester, NHDirectorJames Mccloud · Southport, CTDirectorThomas Nye · Cedarburg, WIDirectorUjwala Mahatme · Cambridge, MADirectorRobert Duggan · Palo Alto, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗